Schoenherr advises AddLife on acquisition of Austrian life sciences company Biomedica Group
By Christian Herbst, Denisa Lazarescu Schoenherr has advised NASDAQ Stockholm listed AddLife AB (publ) (“AddLife”), on the acquisition of Austrian life sciences company Biomedica Medizinprodukte GmbH (“Biomedica”). The acquisition agreement was signed on 26 November 2018. The total purchase price for the acquisition of Biomedica is approx. EUR 39 million, of which 75 % is paid […]